Skip to main content

Peer Review reports

From: Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report

Original Submission
23 Jun 2019 Submitted Original manuscript
25 Nov 2019 Reviewed Reviewer Report - Takaaki Tokito,
5 Dec 2019 Reviewed Reviewer Report - Christian Caglevic
29 Jan 2020 Reviewed Reviewer Report - Reviewer 2
17 Feb 2020 Author responded Author comments - Kazumi Nishino
22 Feb 2020 Reviewed Reviewer Report - Christian Caglevic
6 Mar 2020 Author responded Author comments - Kazumi Nishino
Resubmission - Version 2
17 Feb 2020 Submitted Manuscript version 2
Publishing
18 Mar 2020 Editorially accepted
3 Apr 2020 Article published 10.1186/s40360-020-00404-7

You can find further information about peer review here.

Back to article page